1. Home
  2. XNCR vs GABC Comparison

XNCR vs GABC Comparison

Compare XNCR & GABC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XNCR
  • GABC
  • Stock Information
  • Founded
  • XNCR 1997
  • GABC 1910
  • Country
  • XNCR United States
  • GABC United States
  • Employees
  • XNCR N/A
  • GABC N/A
  • Industry
  • XNCR Biotechnology: Pharmaceutical Preparations
  • GABC Major Banks
  • Sector
  • XNCR Health Care
  • GABC Finance
  • Exchange
  • XNCR Nasdaq
  • GABC Nasdaq
  • Market Cap
  • XNCR 579.3M
  • GABC 1.4B
  • IPO Year
  • XNCR 2013
  • GABC N/A
  • Fundamental
  • Price
  • XNCR $8.80
  • GABC $40.61
  • Analyst Decision
  • XNCR Buy
  • GABC Buy
  • Analyst Count
  • XNCR 7
  • GABC 4
  • Target Price
  • XNCR $27.50
  • GABC $44.50
  • AVG Volume (30 Days)
  • XNCR 788.7K
  • GABC 230.8K
  • Earning Date
  • XNCR 08-04-2025
  • GABC 07-28-2025
  • Dividend Yield
  • XNCR N/A
  • GABC 2.82%
  • EPS Growth
  • XNCR N/A
  • GABC N/A
  • EPS
  • XNCR N/A
  • GABC 2.43
  • Revenue
  • XNCR $127,228,000.00
  • GABC $256,672,000.00
  • Revenue This Year
  • XNCR N/A
  • GABC $44.97
  • Revenue Next Year
  • XNCR $28.84
  • GABC $5.76
  • P/E Ratio
  • XNCR N/A
  • GABC $16.88
  • Revenue Growth
  • XNCR N/A
  • GABC 4.68
  • 52 Week Low
  • XNCR $7.16
  • GABC $32.75
  • 52 Week High
  • XNCR $27.24
  • GABC $47.08
  • Technical
  • Relative Strength Index (RSI)
  • XNCR 54.21
  • GABC 63.04
  • Support Level
  • XNCR $7.93
  • GABC $40.51
  • Resistance Level
  • XNCR $9.48
  • GABC $41.30
  • Average True Range (ATR)
  • XNCR 0.52
  • GABC 0.85
  • MACD
  • XNCR 0.11
  • GABC 0.23
  • Stochastic Oscillator
  • XNCR 73.21
  • GABC 85.05

About XNCR Xencor Inc.

Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.

About GABC German American Bancorp Inc.

German American Bancorp Inc is a bank holding company. The lines of business include Retail and commercial banking business which involves attracting deposits from the general public and using those funds to originate consumer, commercial and agricultural, commercial and agricultural real estate, and residential mortgage loans. These core banking activities also include the sale of residential mortgage loans in the secondary market. Wealth management services which involve providing trust, investment advisory, brokerage and retirement planning services to customers. Insurance operations include the offering of a full range of personal and corporate property and casualty insurance products.

Share on Social Networks: